Steven E. Marx

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings

D. Dobrez, Ângelo do Carmo da Silva Mathes, Michael Amdahl et al. · Nephrology Dialysis Transplantation · 2004 · 114 citations · Full text

Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study

Markus Ketteler, Kévin Martin, Myles Wolf et al. · Nephrology Dialysis Transplantation · 2012 · 99 citations · Full text

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report

William F. McGhan, Maiwenn Al, Jalpa A. Doshi et al. · Value in Health · 2009 · 83 citations

Total Quality Management, Quality Cost, Engineering +13

Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients

W. Kurt Roth, Dorothee Waschk, Steven E. Marx et al. · Transfusion · 1997 · 69 citations

Association of Secondary Hyperparathyroidism with CKD Progression, Health Care Costs and Survival in Diabetic Predialysis CKD Patients

Glen T. Schumock, Dennis L. Andress, Steven E. Marx et al. · Nephron Clinical Practice · 2009 · 49 citations · Full text